The major goals of this Center are to perform basic and applied science, as well as the technological development in all the areas of biodiversity and drugs discovery on the basis of research that uses the state of the art of the chemistry of natural products, synthetic organic chemistry, molecular and structural biology, biochemist, medicinal chemistry, drug design and pharmacological assays.
The specific objectives are the bioprospecting of Brazilian flora to identification the components with an ample specter of biological activities (e.g., antiparasitic, antibacterial, anticancer); selection of promising bioactive compounds for organic synthesis and studies of the relations between the structure and activity (SAR, QSAR); use of strategies of drug design based in the structure of the receiver (SBDD) and the binder (LBDD); use approaches for optimizing compounds-leaders; preclinical efficacy studies, toxicology and pharmacokinetics in vitro and in vivo for the evaluation and optimizing of properties of new drug candidates.
The ultimate goal is the development of new chemical entities (NCEs) with raised potential of innovation for clinical development. Therefore, the CIBFar is not only bases on the abilities and solid scientific knowledge in all the interest areas, but also in an organized structure for the integration of modern approaches in biodiversity and drugs discovery.
CIBfar main characteristic is the well-established infrastructure in terms of skills for technical, financial, technological education and executive management. Maximum integration with the productive sector will be held to identify opportunities and definition of goals. In the educational aspect, the Center counts on the significant experience acquired throughout one decade in education and dissemination of the knowledge carried through in the CEPID-FAPESP.